Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20113920 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects
Conditions: Human Papillomavirus Infection;   Cervical Intraepithelial Neoplasia;   Papillomavirus Vaccines
Interventions: Biological: Boostrix ® Polio;   Biological: GSK Biologicals' HPV-16/18 L1 AS04 vaccine (Cervarix TM)

Indicates status has not been verified in more than two years